Showing results (101-110 of 107) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2024
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanomaSatish Kumar Reddy Noonepalle, Maria Gracia-Hernandez, Nima Aghdam, et al.Nature Protocols|January 27, 2017
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimensXuefeng Liu, Ewa Krawczyk, Frank A Suprynowicz, et al.Oncotarget|December 24, 2016
Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancerOlga A Timofeeva, Nancy Palechor-Ceron, Guanglei Li, et al.Oncotarget|October 10, 2014
The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cellsLymor Ringer, Paul Sirajuddin, Lucas Tricoli, et al.Radiation Oncology (London, England)|March 19, 2013
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceLeonard N Chen, Simeng Suy, Sunghae Uhm, et al.Journal of Hematology & Oncology|March 29, 2011
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancerEric K Oermann, Simeng Suy, Heather N Hanscom, et al.Technology in Cancer Research & Treatment|September 7, 2010
A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancerEric K Oermann, Rebecca S Slack, Heather N Hanscom, et al.Pageof 11